NCT01390805已完成不适用
Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 462
- 主要终点
- The number of adverse events in Japanese subjects with recurrent genital herpes treated with valaciclovir
研究概览
简要总结
The purpose of this study is to collect and assess information on proper use of valaciclovir regarding safety and efficacy of long-term use in suppressive therapy for subjects with recurrent genital herpes.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects who started suppressive therapy for recurrent genital herpes for the first time
排除标准
- •Subjects with a history of hypersensitivity to the ingredients of VALTREX or aciclovir
研究组 & 干预措施
Subjects with recurrent genital herpes
干预措施: Valaciclovir Hydrochloride. (Drug)
结局指标
主要结局
The number of adverse events in Japanese subjects with recurrent genital herpes treated with valaciclovir
时间窗: 1 year
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)VaricellaNCT01390857GlaxoSmithKline379
Unknown
3 期
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsHIV InfectionsHerpes GenitalisHerpes SimplexNCT00005663Glaxo Wellcome
已完成
不适用
Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)Venous ThromboembolismNCT02558465Bayer2,540
终止
2 期
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired InfantsCmv CongenitalCMVCongenital CmvSNHLSensorineural Hearing LossNCT03107871Albert Park10
已完成
3 期
Evaluation Of Valaciclovir In Patients With ChickenpoxVaricellaNCT00169416GlaxoSmithKline43